162 related articles for article (PubMed ID: 21424282)
1. Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.
McCulloch T; Prayle A; Lunn A; Watson AR
Pediatr Nephrol; 2011 Jul; 26(7):1163-6. PubMed ID: 21424282
[TBL] [Abstract][Full Text] [Related]
2. Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients.
Hill PA; Prince HM; Power DA
Pathology; 2000 Aug; 32(3):166-70. PubMed ID: 10968388
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide induced renal rickets.
Lionel AP; Chinnaswamy G; John RR; Mathai S
Indian J Pediatr; 2014 Sep; 81(9):943-5. PubMed ID: 23912821
[TBL] [Abstract][Full Text] [Related]
4. Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.
Matsuura T; Wakino S; Yoshifuji A; Nakamura T; Tokuyama H; Hashiguchi A; Konishi K; Iwasa T; Shoji M; Hosono A; Ohashi K; Chuman H; Itoh H
CEN Case Rep; 2014 Nov; 3(2):226-231. PubMed ID: 28509207
[TBL] [Abstract][Full Text] [Related]
5. Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.
Akilesh S; Juaire N; Duffield JS; Smith KD
Am J Kidney Dis; 2014 May; 63(5):843-50. PubMed ID: 24518127
[TBL] [Abstract][Full Text] [Related]
6. An uncommon presentation of an uncommon nephropathy: the karyomegalic interstitial nephritis.
Lucisano G; Comi N; Cianfrone P; Andreucci M; Piraina V; Talarico R; Giannakakis K; Fuiano G
J Nephrol; 2013; 26(6):1188-91. PubMed ID: 23553526
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide nephrotoxicity in paediatric cancer patients.
Ashraf MS; Brady J; Breatnach F; Deasy PF; O'Meara A
Eur J Pediatr; 1994 Feb; 153(2):90-4. PubMed ID: 8157032
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
Knoppert SN; Keijzer-Veen MG; Valentijn FA; van den Heuvel-Eibrink MM; Lilien MR; van den Berg G; Haveman LM; Stokman MF; Janssens GO; van Kempen S; Broekhuizen R; Goldschmeding R; Nguyen TQ
J Pathol; 2023 Dec; 261(4):455-464. PubMed ID: 37792603
[TBL] [Abstract][Full Text] [Related]
9. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.
Marina NM; Poquette CA; Cain AM; Jones D; Pratt CB; Meyer WH
J Pediatr Hematol Oncol; 2000; 22(2):112-8. PubMed ID: 10779023
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
11. End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
Friedlaender MM; Haviv YS; Rosenmann E; Peylan-Ramu N
Am J Nephrol; 1998; 18(2):131-3. PubMed ID: 9569955
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
[TBL] [Abstract][Full Text] [Related]
14. Karyomegalic interstitial nephropathy following ifosfamide therapy.
Jayasurya R; Srinivas BH; Ponraj M; Haridasan S; Parameswaran S; Priyamvada PS
Indian J Nephrol; 2016; 26(4):294-7. PubMed ID: 27512305
[TBL] [Abstract][Full Text] [Related]
15. Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.
Yonemoto T; Takahashi M; Maru M; Tomioka A; Saito M; Araki Y; Tazaki M; Tsuchiya M; Iwata S; Kamoda H; Ishii T
Int J Clin Oncol; 2016 Aug; 21(4):801-807. PubMed ID: 26792434
[TBL] [Abstract][Full Text] [Related]
16. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
Oberlin O; Habrand JL; Zucker JM; Brunat-Mentigny M; Terrier-Lacombe MJ; Dubousset J; Gentet JC; Schmitt C; Ponvert D; Carrié C
J Clin Oncol; 1992 Sep; 10(9):1407-12. PubMed ID: 1517783
[TBL] [Abstract][Full Text] [Related]
17. [Karyomegalic interstitial nephritis: an atypical case].
Dugo M; Laurino L; Di Martino A; Brunello A; Caberlotto A; Gatti P; Mangino M; Mastrosimone S; Pasi A; Palminteri G; Puggia R; Rizzolo M; Toffolo K; Virgilio B; Zagatti R; Maresca MC
G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545629
[TBL] [Abstract][Full Text] [Related]
18. Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature.
Monga G; Banfi G; Salvadore M; Amatruda O; Bozzola C; Mazzucco G
Clin Nephrol; 2006 May; 65(5):349-55. PubMed ID: 16724656
[TBL] [Abstract][Full Text] [Related]
19. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide nephropathy in patients with sarcoma.
Mashhadi MA; Sanadgol H; Keikhaei M
Iran J Kidney Dis; 2011 Jul; 5(4):238-41. PubMed ID: 21725180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
